[1]CurrentPatentAssignee:OSCOTECINC-US2021/292322,2021,A1Locationinpatent:Paragraph0080
Title: G-749, a novel FLT3 kinase inhibitor, can overcome drug resistance for the treatment of acute myeloid leukemia.
Journal: Blood 20140403
1457983-33-3
1461-97-8 | trans-1,2-Cyclopentanedicarboxylic acid | AA001DMS | MFCD01720262
1464091-43-7 | 2-Chloro-5,7-dihydrofuro[3,4-b]pyridine | AA001DWT | MFCD24386279
14678-02-5 | 5-Amino-3-methylisoxazole | AA001E8N | MFCD00003151
147103-31-9 | α-D-Glucopyranoside, 4-nitrophenyl 2-O-α-D-glucopyranosyl- | AA001EJC | MFCD07369592
147492-57-7 | Fluorinated triethylene glycol monomethyl ether | AA001EU5 | MFCD00156026
14772-92-0 | Cholan-24-oic acid, 7,12-dihydroxy-3-oxo-, methyl ester, (5α,7α,12α)- (9CI) | AA001F3J | MFCD07369531
1481-36-3 | Fluorocyclopentane | AA001FDO | MFCD08059532
950981-11-0 | 4-Thiazolidinone, 2-thioxo-, homopolymer | AA01X3HK | MFCD00005488
1414958-88-5 | C-(5-Bromo-thiazol-2-yl)-methylamine hydrochloride | AA001GE8 | MFCD22689362
1416438-72-6 | 2-Benzyl-2-azaspiro[3.3]heptane | AA001GPP | MFCD22690547